185 results on '"Jennings, Linda W."'
Search Results
2. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts
3. Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR Score’s Ability to Determine Long-term Outcome
4. Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
5. Acute Liver Allograft Antibody-Mediated Rejection: an Inter-Institutional Study of Significant Histopathological Features
6. Interobserver agreement in Hepatitis C grading and staging and in the Banff Grading Schema for acute cellular rejection: the 'Hepatitis C 3' multi-institutional trial experience
7. Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation
8. Basic Statistical Concepts in Nutrition Research
9. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation
10. A Randomized, Multicenter Study Comparing Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Recipients With Chronic Hepatitis C†
11. MELD‐GRAIL‐Na: Glomerular Filtration Rate and Mortality on Liver‐Transplant Waiting List
12. Discovery and Validation of a Biomarker Model (PRESERVE) Predictive of Renal Outcomes After Liver Transplantation
13. Indications for combined liver and kidney transplantation: propositions after a 23-yr experience
14. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease
15. Improved Results of Transplantation for Hepatocellular Carcinoma: A Report From the International Registry of Hepatic Tumors in Liver Transplantation
16. Acute kidney injury following liver transplantation: Definition and outcome
17. Poster Board #-Session: P232-I Survival and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma (Tumors Diagnosed before Transplantation) Are Improving.: Abstract# 889
18. Poster Board #-Session: P217-I Impact of Neoadjuvant Treatment of Hepatocellular Carcinoma on Survival after Liver Transplantation.: Abstract# 874
19. Twenty yearsʼ follow-up of portal vein conduits in liver transplantation
20. Twenty Years of Follow-Up of Aortohepatic Conduits in Liver Transplantation
21. Late acute rejection after liver transplantation impacts patient survival
22. Hepatorenal Syndrome: A Proposal for Kidney After Liver Transplantation (KALT)
23. Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma: A Report From the International Registry of Hepatic Tumors in Liver Transplantation
24. Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation – a clinical and histological examination
25. External Validation of a Pretransplant Biomarker Model (REVERSE) Predictive of Renal Recovery After Liver Transplantation
26. A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal Dysfunction[Link]
27. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis
28. De novo tumors after liver transplantation: A single-institution experience
29. Liver Transplantation for Hepatitis C: Recurrence and Disease Progression in 300 Patients
30. Maternal weight gain in low-income black and hispanic women: evaluation by use of weight-for-height near term
31. Forecasting Methods for Institutional Research.
32. Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients
33. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts
34. Acute liver allograft antibody-mediated rejection:an inter-institutional study of significant histopathological features
35. Response of irritable bowel syndrome with constipation patients administered a combined quebracho/conker tree/M. balsamea Willdextract
36. Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR Score's Ability to Determine Long-term Outcome.
37. Acute liver allograft antibody-mediated rejection: An inter-institutional study of significant histopathological features
38. Cognitive function and regional cerebral blood flow in partial seizures
39. Incidence and Severity of Respiratory Insufficiency Detected by Transcutaneous Carbon Dioxide Monitoring After Cardiac Surgery and Intensive Care Unit Discharge
40. Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation
41. Renal-Sparing Immunosuppressive Protocol Using Okt3 After Liver Transplantation: A 19-Year Single-Institution Experience
42. Effect of Tacrolimus on Survival in Hepatitis C–Infected Patients After Liver Transplantation
43. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease
44. Liver transplantation and health-related quality of life: Scoring differences between men and women
45. Societal Reintegration After Liver Transplantation
46. Use of General Anesthetic Only Vs General Anesthetic Combined with Paravertebral Block for Perioperative Pain Management After First Rib Resection
47. Readmission to the intensive care unit after liver transplantation
48. The Elderly Liver Transplant Recipient: A Call for Caution
49. DE NOVO TUMORS AFTER LIVER TRANSPLANTATION OCCUR IN A SET TIMELINE.
50. DOES MOFETIL MYCOPHENOLATE (MMF) DELAY HEPATITIS C RECURRENCE IN LIVER TRANSPLANT PATIENTS?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.